(BILI) – Company Press Releases
-
Bilibili Inc. to Hold Annual General Meeting on June 28, 2024
-
Bilibili Publishes 2023 Environmental, Social and Governance Report
-
Bilibili Inc. Announces Completion of the Repurchase Right Offer for 1.375% Convertible Senior Notes due 2026
-
Bilibili Inc. Files Its 2023 Annual Report on Form 20-F
-
Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Qiming Venture Partners Becomes a UN PRI Signatory
-
Bilibili Inc. Announces Repurchase Right Notification for 1.375% Convertible Senior Notes due 2026
-
Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on Thursday, March 7, 2024
-
Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange
-
Bilibili Inc. Announces Second Quarter 2023 Financial Results
-
Bilibili Inc. to Report Second Quarter 2023 Financial Results on Thursday, August 17, 2023
-
Bilibili Inc. Announces Results of Annual General Meeting
-
36Kr Hits Two Million Followers on Bilibili; AIGC Technology to Empower Content Creation and Business Growth
-
Bilibili Inc. Announces Completion of the Repurchase Right Offer for Its 1.25% Convertible Senior Notes due 2027
-
Bilibili Inc. Announces First Quarter 2023 Financial Results
-
Bilibili Inc. to Report First Quarter 2023 Financial Results on Thursday, June 1, 2023
-
Bilibili Inc. Announces Repurchase Right Notification for 1.25% Convertible Senior Notes due 2027
-
Bilibili Inc. to Hold Annual General Meeting on June 30, 2023
-
Bilibili Inc. Files Its 2022 Annual Report on Form 20-F
-
Bilibili Publishes 2022 Environmental, Social and Governance Report
-
Bilibili Inc. Announces Inclusion of Its Class Z Ordinary Shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect Programs
-
Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results
-
Bilibili to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Thursday, March 2, 2023
-
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
-
Bilibili Inc. Announces Completion of Equity Offering
-
Bilibili Inc. Prices Notes Repurchases and Equity Offering
-
Bilibili Inc. Announces Proposed Notes Repurchases and Equity Offering
-
Bilibili Inc. Announces Third Quarter 2022 Financial Results
-
Bilibili to Report Third Quarter 2022 Financial Results on Tuesday, November 29, 2022
-
Bilibili Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited
-
Bilibili Inc. Announces Second Quarter 2022 Financial Results
-
Bilibili to Report Second Quarter 2022 Financial Results on Thursday, September 8, 2022
-
Qiming's Portfolio Company InventisBio Lists on STAR Market
-
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
-
Bilibili Inc. Announces Results of Annual General Meeting
-
Bilibili Inc. Announces 2022 First Quarter Financial Results
-
Bilibili to Hold Annual General Meeting on June 30, 2022
-
Bilibili Publishes 2021 Environmental, Social and Governance Report
-
Bilibili Provides Update on Status Under Holding Foreign Companies Accountable Act
-
Bilibili Provides Update on Voluntary Conversion to Dual-Primary Listing on The Main Board of The Stock Exchange of Hong Kong Limited
-
Bilibili Provides Updates on Financial Guidance and Recent Business Developments
-
Bilibili Files Its 2021 Annual Report on Form 20-F
-
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List
-
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market
-
Qiming's Portfolio Company Arrail Group Lists on Main Board of HKEX
-
Bilibili to Pursue Voluntary Conversion to Dual-Primary Listing on The Main Board of The Stock Exchange of Hong Kong Limited
-
Bilibili Inc. Announces 2021 Fourth Quarter and Fiscal Year Financial Results
-
Qiming Venture Partners Welcomes David Chu as IR Partner
-
Bilibili to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
-
Qiming Venture Partners Announces Annual Promotions
Back to BILI Stock Lookup
